InnoCan Pharma Corporation (CSE:INNO)
Canada
· Delayed Price · Currency is CAD 10.80
+0.61 (5.99%)
At close: Dec 5, 2025
InnoCan Pharma Revenue
InnoCan Pharma had revenue of $6.82M USD in the quarter ending September 30, 2025, a decrease of -20.90%. This brings the company's revenue in the last twelve months to $27.03M, down -6.58% year-over-year. In the year 2024, InnoCan Pharma had annual revenue of $29.44M with 115.55% growth.
Revenue (ttm)
$27.03M
Revenue Growth
-6.58%
P/S Ratio
1.29
Revenue / Employee
n/a
Employees
n/a
Market Cap
48.59M CAD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Loblaw Companies | 63.15B |
| Dollarama | 6.69B |
| George Weston | 63.75B |
| Metro | 22.01B |
| Saputo | 19.10B |
| Empire Company | 31.48B |
| Premium Brands Holdings | 7.22B |
| Maple Leaf Foods | 5.10B |